JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffith, W. H.
Right arrow Articles by Sim, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffith, W. H.
Right arrow Articles by Sim, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE

Comparison of 4-aminopyridine and tetrahydroaminoacridine on basal forebrain neurons

WH Griffith and JA Sim

Department of Medical Pharmacology and Toxicology, College of Medicine, Texas A&M University, College Station.

This study was designed to investigate the ability of 4-aminopyridine (4-AP) and tetrahydroaminoacridine (THA) to reduce several potassium conductances in cells of the medial septum and nucleus of the diagonal band. Intracellular recording and single electrode voltage-clamp techniques were used in an in vitro brain slice preparation. Both 4-AP (100-300 microM) and THA (300 microM) reduced a transient outward current (A-current), whereas only 4-AP increased the release of spontaneous postsynaptic potentials and significantly prolonged action potential duration. High concentrations of THA (1 mM) were needed to significantly increase action potential duration but these levels of THA were still ineffective in eliciting spontaneous postsynaptic potentials. THA (300 microM), but not 4-AP, had the additional effect of reducing time-dependent membrane rectification (Q-current) in one cell type. Our results demonstrate that both cholinergic and non- cholinergic cells are sensitive to pharmacological concentrations of both compounds.

Volume 255, Issue 3, pp. 986-993, 12/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. Wu, S. S. Newton, J. B. Atkins, C. Xu, R. S. Duman, and M. Alreja
Acetylcholinesterase Inhibitors Activate Septohippocampal GABAergic Neurons via Muscarinic but Not Nicotinic Receptors
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 535 - 543.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
J. H. Jhamandas, K. H. Harris, D. MacTavish, and B. S. Jassar
Novel Excitatory Actions of Galanin on Rat Cholinergic Basal Forebrain Neurons: Implications for Its Role in Alzheimer's Disease
J Neurophysiol, February 1, 2002; 87(2): 696 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
B. S. Jassar, K. H. Harris, P. M. Ostashewski, and J. H. Jhamandas
Ionic Mechanisms of Action of Neurotensin in Acutely Dissociated Neurons From the Diagonal Band of Broca of the Rat
J Neurophysiol, January 1, 1999; 81(1): 234 - 246.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.